Terms: = Lung cancer AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF AND Prognosis
16 results:
1. Multiomics analysis revealed the mechanisms related to the enhancement of proliferation, metastasis and EGFR-TKI resistance in EGFR-mutant LUAD with ARID1A deficiency.
Sun D; Feng F; Teng F; Xie T; Wang J; Xing P; Qian H; Li J
Cell Commun Signal; 2023 Mar; 21(1):48. PubMed ID: 36869329
[TBL] [Abstract] [Full Text] [Related]
2. Downregulation of KIF15 inhibits the tumorigenesis of non-small-cell lung cancer via inactivating Raf/MEK/ERK signaling.
Luo Y; Zhang B; Xu L; Li M; Wu J; Zhou Y; Li Y
Histol Histopathol; 2022 Mar; 37(3):269-285. PubMed ID: 34908156
[TBL] [Abstract] [Full Text] [Related]
3. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
[TBL] [Abstract] [Full Text] [Related]
4. Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis.
Yang CW; Wang SF; Yang XL; Wang L; Niu L; Liu JX
Medicine (Baltimore); 2018 Feb; 97(7):e9738. PubMed ID: 29443735
[TBL] [Abstract] [Full Text] [Related]
5. The targeted inhibition of Hsp90 by a synthetic small molecule, DPide offers an effective treatment strategy against TNBCs.
Oh YJ; Park SY; Seo YH
Oncol Rep; 2018 Apr; 39(4):1775-1782. PubMed ID: 29436674
[TBL] [Abstract] [Full Text] [Related]
6. PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways.
Naidu S; Shi L; Magee P; Middleton JD; Laganá A; Sahoo S; Leong HS; Galvin M; Frese K; Dive C; Guzzardo V; Fassan M; Garofalo M
Sci Rep; 2017 Nov; 7(1):15441. PubMed ID: 29133857
[TBL] [Abstract] [Full Text] [Related]
7. Overexpression of regulator of G protein signaling 11 promotes cell migration and associates with advanced stages and aggressiveness of lung adenocarcinoma.
Yang SH; Li CF; Chu PY; Ko HH; Chen LT; Chen WW; Han CH; Lung JH; Shih NY
Oncotarget; 2016 May; 7(21):31122-36. PubMed ID: 27105500
[TBL] [Abstract] [Full Text] [Related]
8. Preclinical Evaluation of a Novel Orally Available SRC/Raf/VEGFR2 Inhibitor, SKLB646, in the Treatment of Triple-Negative Breast cancer.
Zheng MW; Zhang CH; Chen K; Huang M; Li YP; Lin WT; Zhang RJ; Zhong L; Xiang R; Li LL; Liu XY; Wei YQ; Yang SY
Mol Cancer Ther; 2016 Mar; 15(3):366-78. PubMed ID: 26721945
[TBL] [Abstract] [Full Text] [Related]
9. BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis.
Cremolini C; Di Bartolomeo M; Amatu A; Antoniotti C; Moretto R; Berenato R; Perrone F; Tamborini E; Aprile G; Lonardi S; Sartore-Bianchi A; Fontanini G; Milione M; Lauricella C; Siena S; Falcone A; de Braud F; Loupakis F; Pietrantonio F
Ann Oncol; 2015 Oct; 26(10):2092-7. PubMed ID: 26153495
[TBL] [Abstract] [Full Text] [Related]
10. Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis.
Koinuma J; Akiyama H; Fujita M; Hosokawa M; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
Cancer Sci; 2012 Mar; 103(3):577-86. PubMed ID: 22129094
[TBL] [Abstract] [Full Text] [Related]
11. Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival.
Huerta-Yepez S; Yoon NK; Hernandez-Cueto A; Mah V; Rivera-Pazos CM; Chatterjee D; Vega MI; Maresh EL; Horvath S; Chia D; Bonavida B; Goodglick L
BMC Cancer; 2011 Jun; 11():259. PubMed ID: 21689459
[TBL] [Abstract] [Full Text] [Related]
12. Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy.
Li Y; Sun Z; Cunningham JM; Aubry MC; Wampfler JA; Croghan GA; Johnson C; Wu D; Aakre JA; Molina J; Wang L; Pankratz VS; Yang P
Clin Cancer Res; 2011 Jun; 17(11):3830-40. PubMed ID: 21636554
[TBL] [Abstract] [Full Text] [Related]
13. RAF expression in human astrocytic tumors.
Hagemann C; Gloger J; Anacker J; Said HM; Gerngras S; Kühnel S; Meyer C; Rapp UR; Kämmerer U; Vordermark D; Flentje M; Roosen K; Vince GH
Int J Mol Med; 2009 Jan; 23(1):17-31. PubMed ID: 19082503
[TBL] [Abstract] [Full Text] [Related]
14. Combined targeted therapies in non-small cell lung cancer: a winner strategy?
Cascone T; Gridelli C; Ciardiello F
Curr Opin Oncol; 2007 Mar; 19(2):98-102. PubMed ID: 17272980
[TBL] [Abstract] [Full Text] [Related]
15. Common patterns of genetic evolution in human solid tumors.
Shackney SE; Shankey TV
Cytometry; 1997 Sep; 29(1):1-27. PubMed ID: 9298807
[TBL] [Abstract] [Full Text] [Related]
16. [Recent progress in the biology of small cell bronchial carcinoma].
Thomas F; Arriagada R; Le Chevalier T; Poupon MF
Rev Mal Respir; 1988; 5(5):451-61. PubMed ID: 2847257
[TBL] [Abstract] [Full Text] [Related]
